Vaxcyte, Inc.
PCVX· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2020 | Q1 2019 |
|---|---|---|
| Net Income | -$27.14M | -$13.67M |
| EPS Diluted | -$6.70 | -$3.72 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaxcyte, Inc. · CIK 1649094 · Engraved from SEC EDGAR